Factors determining cardiovascular and renal outcomes after adrenalectomy in patients with aldosterone-producing adrenal adenoma

Tohoku Journal of Experimental Medicine

Volumn 218, Issue 1, 2009, Pages 17-24

  Chiou, Terry Ting Yu ^a   Chiang, Po Hui ^a   Fuh, Morgan ^a   Liu, Rue Tsuan ^a   Lee, Wei Ching ^a   Lee, Wen Chin ^a   Ng, Hwee Yeong ^a   Tsai, Yu Che ^a   Chuang, Fong Rong ^a   Huang, Chao Cheng ^a   Lee, Chien Te ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Adrenal adenoma; Aldosteronism; Blood pressure; LVH; Renal function

Indexed keywords

ALDOSTERONE; POTASSIUM; RENIN;

ADRENAL CORTEX ADENOMA; ADRENALECTOMY; ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE PRODUCING ADRENAL ADENOMA; ARTICLE; CARDIOVASCULAR FUNCTION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPOKALEMIA; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PREOPERATIVE EVALUATION; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE;

ADRENAL CORTEX NEOPLASMS; ADRENALECTOMY; ADRENOCORTICAL ADENOMA; ADULT; AGED; ALDOSTERONE; CARDIOVASCULAR SYSTEM; FEMALE; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; ROC CURVE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 69249158066     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.218.17     Document Type: Article

References (36)

1. Blumenfeld, J.D., Sealey, J.E., Schlussel, Y., Sos, T.A., Atlas, S.A., Müller, F.B., Acevedo, R., Ulick, S. & Laragh, J.H. (1994) Diagnosis and treatment of primary hyperaldosteronism. Ann. Intern. Med., 121, 877-885.
2. Brown, M.A., Cramp, H.A., Zammit, V.C. & Whitworth, J.A. (1996) Primary hyperaldosteronism: a missed diagnosis in 'essential hypertensives'? Aust. N. Z. J. Med., 26, 533-538.
3. Catena, C., Colussi, G., Lapenna, R., Nadalini, E., Chiuch, A., Gianfagna, P. & Sechi, L.A. (2007) Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension, 50, 911-918.
4. Catena, C., Colussi, G., Nadalini, E., Chiuch, A., Baroselli, S., Lapenna, R. & Sechi, L.A. (2008) Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch. Intern. Med., 168, 80-85.
5. Celen, O., O'Brien, M.J., Melby, J.C. & Beazley, R.M. (1996) Factors influencing outcome of surgery for primary aldosteronism. Arch. Surg., 131, 646-650.
6. Connell, J.M., McaKenzie, S.M., Freel, E.M., Fraser, R. & Davies, E. (2008) A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocr. Rev., 29, 133-154.
7. Fogari, R., Preti, P., Zoppi, A., Rinaldi, A., Fogari, E. & Mugellini, A. (2007) Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test. Hypertens. Res., 30, 111-117.
8. Foo, R., O'Shaughnessy, K.M. & Brown, M.J. (2001) Hyperaldosteronism: recent concept, diagnosis, and management. Postgrad. Med. J., 77, 639-644.
9. Fronticelli, C.M., Ferrero, A., Quiriconi, F., Bargoni, A. & Masenti, E. (1995) Primary hyperaldosteronism. Analysis of risk factors associated with persistent postoperative hypertension. Int. Surg., 80, 175-177.
10. Fukudome, Y., Fujii, K., Arima, H., Ohya, Y., Tsuchihashi, T., Abe, I. & Fujishima, M. (2002) Discriminating factors for recurrent hypertension in patients with primary aldosteronism after adrenalectomy. Hypertens. Res., 25, 11-18.
11. Goligorsky, M.S. (2007) Frontiers in nephrology: viewing the kidney through the heart - endothelial dysfunction in chronic kidney disease. J. Am. Soc. Nephrol., 18, 2833-2835.
12. Gordon, R.D. (1994) Mineralcorticoid hypertension. Lancet, 344, 240-243.
13. Holaj, R., Zelinka, T., Wichterle, D., Petrák, O., Strauch, B. & Widimský, J. Jr. (2007) Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension. J. Hypertens., 25, 1451-1457.
14. Horita, Y., Inenaga, T., Nakahama, H., Ishibashi-Ueda, H., Kawano, Y., Nakamura, S., Horio, T., Okuda, N., Ando, M. & Takishita, S. (2001) Cause of residual hypertension after adrenalectomy in patients with primary aldosteronism. Am. J. Kidney Dis., 37, 884-889.
15. Levey, A.S., Bosch, J.P., Lewis, J.B., Greene, T., Rogers, N. & Roth, D. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med., 130, 461-470.
16. Lumachi, F., Ermani, M., Basso, S.M., Armanini, D., Iacobone, M. & Favia, G. (2005) Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature. Am. Surg., 71, 864-869.
17. Lund, J., Nielsen, M. & Giese, J. (1981) Prevalence of primary aldosteronism. Acta Med. Scand. Suppl., 646, 54-57.
18. Meyer, A., Brabant, G. & Behrend, M. (2005) Long-term follow-up after adrenalectomy for primary aldosteronism. World J. Surg., 29, 155-159.
19. Milliez, P., Girerd, X., Plouin, P.F., Blacher, J., Safar, M.E. & Mourad, J.J. (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J. Am. Coll. Cardiol., 45, 1243-1248.
20. Mosso, L., Carvajal, C., Gonzalez, A., Barraza, A., Avila, F., Montero, J., Huete, A., Gederlini, A. & Fardella, C.E. (2003) Primary aldosteronism and hypertensive disease. Hypertension, 42, 161-165.
21. Mulatero, P., Stowasser, M., Loh, K.C., Fardella, C.E., Gordon, R.D., Mosso, L., Gomez-Sanchez, C.E., Veglio, F. & Young, W.F. Jr. (2004) Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J. Clin. Endocrinol. Metab., 89, 1045-1050.
22. Neade, T. & Uribarri, J. (2008) Diet, inflammation, and chronic kidney disease: getting to the heart of the matter. Semin. Dial., 21, 331-337.
23. Obara, T., Ito, Y., Okamoto, T., Kanaji, Y., Yamashita, T., Aiba, M. & Fujimoto, Y. (1992) Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism. Surgery, 112, 987-993.
24. Omura, M., Sasano, H., Saito, J., Yamaguchi, K., Kakuta, Y. & Nishikawa, T. (2006) Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens. Res., 29, 883-889.
25. Proye, C.A., Mulliez, E.A., Carnaille, B.M., Lecomte-Houcke, M., Decoulx, M., Wémeau, J.L., Lefebvre, J., Racadot, A., Ernst, O., Huglo, D. & Carré, A. (1998) Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism? Surgery, 124, 1128-1133.
26. Rayner, B. (2008) Primary aldosteronism and aldosterone-associated hypertension. J. Clin. Pathol., 61, 825-831.
27. Ribstein, J., Du Cailar, G., Fesler, P. & Mimran, A. (2005) Relative glomerular hyperfiltration in primary aldosteronism. J. Am. Soc. Nephrol., 16, 1320-1325.
28. Rossi, G.P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., Mallamaci, F., Mannelli, M., Mattarello, M.J., Moretti, A., Palumbo, G., Parenti, G., Porteri, E., Semplicini, A., Rizzoni, D., Rossi, E., Boscaro, M., Pessina, A.C., Mantero, F. & PAPY Study Investigators. (2006a) A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J. Am. Coll. Cardiol., 48, 2293-2300.
29. Rossi, G.P., Bernini, G., Desideri, G., Fabris, B., Ferri, C., Giacchetti, G., Letizia, C., Maccario, M., Mannelli, M., Matterello, M.J., Montemurro, D., Palumbo, G., Rizzoni, D., Rossi, E., Pessina, A.C., Mantero, F. & PAPY Study Participants. (2006b) Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension, 48, 232-238.
30. Rossi, G.P., Bolognesi, M., Rizzoni, D., Seccia, T.M., Piva, A., Porteri, E., Tiberio, G.A., Giulini, S.M., Agabiti-Rosei, E. & Pessina, A.C. (2008) Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension, 51, 1366-1371.
31. Sawka, A.M., Young, W.F., Thompson, G.B., Grant, C.S., Farley, D.R., Leibson, C. & van Heerden, J.A. (2001) Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann. Intern. Med., 135, 258-261.
32. Sechi, L.A., Novello, M., Lapenna, R., Baroselli, S., Nadalini, E., Colussi, G.L. & Catena, C. (2006) Long-term renal outcomes in patients with primary aldosteronism. JAMA., 295, 2638-2645.
33. Wu, V.C., Chueh, S.C., Chang, H.W., Lin, W.C., Liu, K.L., Li, H.Y., Lin, Y.H., Wu, K.D. & Hsieh, B.S. (2008) Bilateral aldosterone-producing adenomas: differentiation from bilateral adrenal hyperplasia. Q. J. M., 101, 13-22.
34. Young, W. (1999) Primary aldosteronism: a common and curable form of hypertension. Cardiol. Rev., 7, 207-214.
35. Zarnegar, R., Young, W.F. Jr., Lee, J., Sweet, M.P., Kebebew, E., Farley, D.R., Thompson, G.B., Grant, C.S., Clark, O.H. & Duh, Q.Y. (2008) The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann. Surg., 247, 511-518.
36. Zoccali, C. (2007) The endothelium as a target in renal diseases. J. Nephrol., 20 Suppl 12, S39-44.